VIALASE
ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma. The company's system focuses on the development of micron-resolution OCT image-guided femtosecond laser technology to create micron-sized customized drainage channels through the trabecular meshwork that connects the anterior chamber to the Schlemm's canal without surgically opening or penetrating the eye, enabling medical professionals to improve glaucoma management with its efficient non-invasive treatment. ViaLase was incorporated in 2019 and is headquartered in Corona Del Mar, California.
VIALASE
Industry:
Health Care Medical Device Wellness
Founded:
2019-01-01
Address:
Corona Del Mar, California, United States
Country:
United States
Website Url:
http://www.vialase.com
Total Employee:
11+
Status:
Active
Contact:
949-538-6623
Total Funding:
78.93 M USD
Technology used in webpage:
Cloudflare Hosting ATT
Similar Organizations
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Fitternity
India's largest online fitness platform that provides an integrated eco-system to help users start & sustain their fitness journey.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
metaMe Health
MetaMe Health develops FDA-cleared prescription digital therapeutics for the treatment of gastrointestinal conditions.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Turn Medical
Turn Medical is a medical device company delivering healthcare solutions from patients to clinicians.
Current Advisors List
Current Employees Featured
Founder
Investors List
Arboretum Ventures
Arboretum Ventures investment in Series C - ViaLase
Falcon Vision
Falcon Vision investment in Series C - ViaLase
Venture Investors
Venture Investors investment in Series C - ViaLase
Arboretum Ventures
Arboretum Ventures investment in Series A - ViaLase
Venture Investors
Venture Investors investment in Series A - ViaLase
Versant Ventures
Versant Ventures investment in Series A - ViaLase
Official Site Inspections
http://www.vialase.com Semrush global rank: 9.86 M Semrush visits lastest month: 300
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ViaLase"
ViaLase | Redefining Glaucoma Treatment
At vialase ®, we're fueling the practice of noninvasive interventional glaucoma With 200 years of combined experience developing femtosecond laser technology, the ViaLase team is …See details»
About ViaLase | Leaders in Non-Invasive Glaucoma Treatment
ViaLase ® is focused on fueling the practice of noninvasive interventional glaucoma with the introduction of the world's first femtosecond laser, image-guided, high-precision trabeculotomy …See details»
ViaLase Closes $40 million Series C Financing to Advance First ...
ALISA VIEJO, CA — April 1, 2024 — ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today …See details»
ViaLase - Crunchbase Company Profile & Funding
ViaLase was incorporated in 2019 and is headquartered in Corona Del Mar, California. A femtosecond laser surgical system for non-invasively creating drainage channels in the trabecular meshwork to treat glaucoma. A device …See details»
ViaLase Closes $40 million Series C Financing to Advance First ...
Apr 1, 2024 · ViaLase, Inc. is a globally-minded, venture and strategic capital-backed, clinical stage medical technology company located in Aliso Viejo, CA. ViaLase is focused on …See details»
Seeing is Believing | Vialase
ViaLase’s pioneering femtosecond laser-based technology brings a new level of imaging and precision to glaucoma care. Our platform is designed to: Enable surgeons to intervene early with a noninvasive, nonpharmacologic procedure …See details»
ViaLase Receives CE Mark for First Femtosecond Laser for the
Jul 30, 2024 · The ViaLase Laser combines state-of-the-art femtosecond laser technology with micron-level image guidance to deliver the first femtosecond laser, image-guided, high …See details»
Fueling FLigHT: Vialase’s Novel Incision-Free Glaucoma Solution, …
Sep 7, 2024 · Rick Lewis, Chief Medical Officer at ViaLase (Aliso Viejo, CA, USA), took to the stage at the ESCRS 2024 iNovation Day in Barcelona to share the company’s journey from …See details»
ViaLase seeks to disrupt glaucoma treatment paradigm with new ...
Oct 12, 2022 · ViaLase is a medical device company, it's venture backed, out of Southern California. We are focused on disrupting the current conventional glaucoma treatment …See details»
First-in-Human Safety Study of Femtosecond Laser …
Dec 30, 2022 · The ViaLase Laser System (ViaLase Inc) is a novel, image-guided femtosecond laser designed to noninvasively create a channel connecting the anterior chamber to the Schlemm’s canal with micron precision, thus …See details»
ViaLase Receives CE Mark for First Femtosecond Laser for the …
ALISO VIEJO, CA — July 30, 2024 — ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today …See details»
ViaLase Closes $40 million Series C Financing to Advance First ...
Apr 1, 2024 · ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it has …See details»
ASCRS 2024: An update from ViaLase on its technology for a ...
Apr 29, 2024 · ViaLase is a startup surgical company that is trying to treat glaucoma by creating a channel of 500 microns wide in the trabecular meshwork. We use a nonincisional technique to …See details»
VIALASE ANNOUNCES POSITIVE RESULTS OF FIRST-IN-HUMAN …
Mar 2, 2023 · ViaLase, Inc. is a globally-minded, venture capital-backed, clinical stage medical technology company located in Aliso Viejo, CA. ViaLase is focused on disrupting the …See details»
ViaLase Completes Enrollment for the Pivotal VIA-002 Trial of the ...
Oct 30, 2023 · The ViaLase Laser combines the precision of femtosecond laser technology and the accuracy of micron-level image guidance to deliver the world's first femtosecond laser …See details»
ViaLase Receives CE Mark for First Femtosecond Laser for the …
Jul 30, 2024 · ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it has …See details»
ViaLase Completes Enrollment for the Pivotal VIA-002 Trial of the ...
ALISA VIEJO, CA — October 30, 2023 — ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment …See details»
ViaLase CEO talks innovations in glaucoma treatment
Sep 21, 2021 · Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the …See details»
ViaLase receives CE mark for femtosecond laser to treat glaucoma
Jul 30, 2024 · The ViaLase laser received a CE mark for the treatment of adults with primary open-angle glaucoma, according to a press release. The device combines a femtosecond …See details»
ViaLase Founder and CEO Tibor Juhasz, Ph.D., Receives 2022 …
ALISA VIEJO, Calif., Sept. 28, 2022 /PRNewswire/ -- ViaLase, Inc., today announced that the company's founder and CEO, Tibor Juhasz, Ph.D., was among five researchers who received …See details»